Who invested in NX Pharmagen?
NX Pharmagen's investors include Keyhorse Capital.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$6.7Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
No investor was named in the report.
Reported by sec.govSEC filing: $773K sold, first sale Jun 2013
No investor was named in the report.
From a historical funding record
From the SEC filings it signed: 1 on the team.
On the board, as filediAlan EzrinRobert Saunders
NX Pharmagen's investors include Keyhorse Capital.
NX Pharmagen has raised $6.7M across 4 rounds since 2012.
NX Pharmagen's most recent round was a Debt of $590K in Oct 2022.
NX Pharmagen's largest round on record is $3.5M (Seed), in Jan 2012.
NX Pharmagen's first round on record, in Oct 2022, was backed by Keyhorse Capital.
NX Pharmagen's latest named round is a Debt, in Oct 2022.
NX Pharmagen is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.